The Metabolic Effects of Ginseng Oligopeptide Preparation on Non- Alcoholic Fatty Liver Disease With Obesity: a Randomized Controlled Double-blind Trial

This study focuses on understanding how ginseng oligopeptide might help people suffering from non-alcoholic fatty liver disease who are also dealing with obesity. The main goal is to see if this natural compound can be an effective way to prevent and treat this liver condition. Non-alcoholic fatty liver disease is a common issue, especially among those with obesity, and finding new, effective ways to manage it is important for improving the health and quality of life for many people. Participants in this study are divided into two groups. One group receives the ginseng oligopeptide by mouth, while the other group receives a placebo, which is a harmless pill with no active ingredients. Researchers are measuring several health indicators, such as liver function, blood lipid levels, and blood glucose, as well as conducting liver ultrasounds to observe any changes. This helps determine how effective the ginseng oligopeptide is at improving liver health and managing the disease. The study aims to provide insights into how this treatment might benefit individuals with this condition.